ScholarIQanswers from OpenAlex
Shanghai University of Traditional Chinese Medicine
InstitutionResearch output, impact & collaborations
Shanghai University of Traditional Chinese Medicine is a institution indexed in ScholarIQ from OpenAlex.
What is known about Shanghai University of Traditional Chinese Medicine?
ScholarIQrecord summary
Shanghai University of Traditional Chinese Medicine is a research organisation in Shanghai, CN. OpenAlex records 39,972 works and 1,923,063 citations for it. 17,311 researchers list it as their most recent affiliation.
How many works does Shanghai University of Traditional Chinese Medicine have?
ScholarIQindexed works
Shanghai University of Traditional Chinese Medicine has 39,972 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shanghai University of Traditional Chinese Medicine have?
ScholarIQcitation count
Shanghai University of Traditional Chinese Medicine has 1,923,063 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Shanghai University of Traditional Chinese Medicine?
ScholarIQresearcher count
Shanghai University of Traditional Chinese Medicine has 17,311 researchers in the ScholarIQ index.
What is the average h-index at Shanghai University of Traditional Chinese Medicine?
ScholarIQavg h-index
Shanghai University of Traditional Chinese Medicine has an average h-index of 43.6 in OpenAlex.
What is the ROR of Shanghai University of Traditional Chinese Medicine?
ScholarIQror
The ROR for Shanghai University of Traditional Chinese Medicine is on the source record.
What is the OpenAlex record for Shanghai University of Traditional Chinese Medicine?
ScholarIQopenalex
The OpenAlex for Shanghai University of Traditional Chinese Medicine is on the source record.
Who are the most-cited researchers behind Shanghai University of Traditional Chinese Medicine?
ScholarIQtop researchers by citations
What are the most-cited papers on Shanghai University of Traditional Chinese Medicine?
ScholarIQmost cited works
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Takashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A. Shukla, Zhi Rong Qian, Ofir Cohen, Reiko Nishihara, Samira Bahl, Yin Cao, Ali Amin‐Mansour, Mai Yamauchi, Yasutaka Sukawa, Chip Stewart, Mara Rosenberg, Kosuke Mima, Kentaro Inamura, Katsuhiko Nosho, Jonathan A. Nowak, Michael S. Lawrence, Edward L. Giovannucci, Andrew T. Chan, Kimmie Ng, Jeffrey A. Meyerhardt, Eliezer M. Van Allen, Gad Getz, Stacey B. Gabriel, Eric S. Lander, Catherine J. Wu, Charles S. Fuchs, Shuji Ogino, Levi A. Garraway
<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma
Kosuke Mima, Yasutaka Sukawa, Reiko Nishihara, Zhi Rong Qian, Mai Yamauchi, Kentaro Inamura, Sun A. Kim, Atsuhiro Masuda, Jonathan A. Nowak, Katsuhiko Nosho, Aleksandar D. Kostic, Marios Giannakis, Hideo Watanabe, Susan Bullman, Danny A. Milner, Curtis C. Harris, Edward L. Giovannucci, Levi A. Garraway, Gordon J. Freeman, Glenn Dranoff, Andrew T. Chan, Wendy S. Garrett, Curtis Huttenhower, Charles S. Fuchs, Shuji Ogino
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Catherine S. Grasso, Marios Giannakis, Daniel K. Wells, Tsuyoshi Hamada, Xinmeng Jasmine Mu, Michael J. Quist, Jonathan A. Nowak, Reiko Nishihara, Zhi Rong Qian, Kentaro Inamura, Teppei Morikawa, Katsuhiko Nosho, Gabriel Abril-Rodríguez, Charles M. Connolly, Helena Escuin-Ordinas, Milan S. Geybels, William M. Grady, Li Hsu, Siwen Hu‐Lieskovan, Jeroen R. Huyghe, Yeon Joo Kim, Paige Krystofinski, Mark D.M. Leiserson, Dennis Montoya, Brian B. Nadel, Matteo Pellegrini, Colin C. Pritchard, Cristina Puig-Saus, Elleanor H. Quist, Benjamin J. Raphael, Stephen J. Salipante, Daniel Sanghoon Shin, Eve Shinbrot, Brian H. Shirts, Sachet A. Shukla, Janet L. Stanford, Wei Sun, Jennifer Tsoi, Alexander Upfill‐Brown, David A. Wheeler, Catherine J. Wu, Ming Yu, Syed Hassan Ejaz Zaidi, Jesse M. Zaretsky, Stacey Gabriel, Eric S. Lander, Levi A. Garraway, Thomas J. Hudson, Charles S. Fuchs, Antoni Ribas, Shuji Ogino, Ulrike Peters
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Xiaotian Zhang, Liang Han, Ziyu Li, Yingwei Xue, Yanong Wang, Zhiwei Zhou, Jiren Yu, Zhaode Bu, Lin Chen, Yian Du, Xinbao Wang, Aiwen Wu, Guoli Li, Xiangqian Su, Gang Xiao, Ming Cui, Dan Wu, Li Chen, Xiaojiang Wu, Yanbing Zhou, Lianhai Zhang, Chengxue Dang, Yulong He, Zhongtao Zhang, Yihong Sun, Yong Li, Huanqiu Chen, Yuxian Bai, Changsong Qi, Peiwu Yu, Guanbao Zhu, Jian Suo, Baoqing Jia, Leping Li, Ze-Ning Huang, Fei Li, Yingjiang Ye, Huimian Xu, Xin Wang, Yannan Yuan, E Jian‐Yu, Xiangji Ying, Chen Yao, Lin Shen, Jiafu Ji
How much of the research on Shanghai University of Traditional Chinese Medicine is open access?
ScholarIQopen access share
67%OPEN ACCESS